This article is based on an interview with Rost, Pharma's Black Knight.
This article describes best exhibit marketing practices and how to measure the effectives of your exhibit.
In one fell swoop the new erectile dysfuntion (ED) 'disease awareness' ads have expanded the market for ED while at the same time managed to come up smelling like roses by complying with PhRMA's Guiding Principles for DTC Advertising. 'Disease mongering' (aka, 'indication bloat') -- or, if you prefer, 'disease awareness'-- efforts are a rising tide that will float all ED drug ships.
Over 60 drug ads that appeared in several major consumer magazines were analyzed. In each, the space allocated to images, benefit statements, risk information, and the brief summary was measured. This article summarizes the findings.
The author argues that the pharmaceutical industry should make a more aggressive push towards the inclusion of their clinically relevant content at the point-of-prescription in on-line managed care formulary lookups and ePrescribing transactions. Only then will the industry begin to change what is looking like a threatening future to one which offers the industry a more level playing field.
The pharmaceutical industry is struggling to develop an eMarketing strategy in Europe, which is comprised of many relatively small markets (the member countries of the EU) having significant cultural and language differences.
There's blood in the water and ad agencies are circlingbiotech companies, trying to entice them into transforming themselves into marketing machines. Some agency people suggest that biotech needs to engage in traditional direct-to-consumer (DTC) advertising. Biotech, however, needs more than DTC as usual.
An Interview with eMarketer Senior Analyst Lisa Phillips
This article is an edited transcript of the June 2006, Pharma Marketing Roundtable discussion, which was devoted to trends in commercial support of CME.
This article is a summary of a presentation made before a pharmaceutical brand team on marketing tactics that are viable now and in the future, how to avoid risk by balancing risk vs. impact, and what the marketing mix trends will be one to five years out.